>

Vertex Pharmaceuticals Market Capitalization

<div class='circular--portrait' style='background:#754DEB;color: white;font-size:3em;padding-top: 40px;;'>VRT</div>
VRTX -- USA Stock  

Fiscal Quarter End: March 31, 2020  

Market Capitalization is likely to grow to about 56 B in 2020. Vertex Pharmaceuticals market capitalization fundamental analysis lookup allows you to check this and other indicators for Vertex Pharmaceuticals Incorpor or any other equity instrument. You can also select from a set of available indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations. Please continue to Equity Screeners to view more equity screening tools
Symbol
Refresh

Vertex Pharmaceuticals Market Capitalization Analysis

Market Capitalization is total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
 2017 2018 2019 2020 (projected)
Receivables310.25 M414.87 M373.38 M402.86 M
Inventories111.83 M124.36 M111.92 M120.76 M
Vertex Pharmaceuticals Incorporated engages in developing and commercializing therapies for treating cystic fibrosis. The company was founded in 1989 and is headquartered in Boston, Massachusetts. Vertex Pharmaceuticals operates under Pharmaceuticals And Biosciences classification in USA and is traded on BATS Exchange.
ReceivablesInventories
Market Cap 
 = 
Shares Outstanding 
X  
Share Price 
More About Market Capitalization | All Equity Analysis
Vertex Pharmaceuticals Market Capitalization  =
55.96 B
ValuationFundamentalsBuy or Sell

Vertex Pharmaceuticals Market Capitalization Over Time Pattern

 Vertex Pharmaceuticals Market Capitalization 
    
  Timeline 

About Market Capitalization

In most publications or references market cap is broken down into the mega cap, large cap, mid cap, small cap, micro cap, and nano cap. Market Cap is a measurement of business as total market value of all of outstanding shares at a given time, and can be used to compare different companies based on their size.
Compare to competition
Accumulated Other Comprehensive Income
Based on recorded statements the market capitalization of Vertex Pharmaceuticals Incorpor is about 55.96 B. This is 332.41% higher than that of the Healthcare sector, and 1080.37% higher than that of Biotechnology industry, The Market Capitalization for all stocks is 194.07% lower than the firm.

Vertex Pharmaceuticals Market Capitalization Peer Comparison

  Market Capitalization 
    
  Vertex Pharmaceuticals Comparables 
Vertex Pharmaceuticals is rated below average in market capitalization category among related companies.

Vertex Pharmaceuticals current financial ratios